Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Basser

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Stem Cells (Dayton, Ohio)|September 30, 2000
Early Australian clinical studies with pegylated recombinant human megakaryocyte growth and development factorR L Basser
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
Dose-intensive chemotherapy in breast cancer--the need for appropriate measures of outcomeR L Basser
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
New developments in high-dose chemotherapy for breast cancerR L Basser
Stem Cells (Dayton, Ohio)|January 1, 1996
The role of platelet growth factors in cancer therapyK Clarke, R L Basser
International Journal of Hematology|January 17, 2002
Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agentsR L Basser, C G Begley
Seminars in Hematology|June 1, 2000
Biologic and structural differences of thrombopoietic growth factorsC G Begley, R L Basser
Cancer Treatment Reviews|January 1, 1993
Strategies for prevention of anthracycline cardiotoxicityR L Basser, M D Green
Current Opinion in Oncology|February 1, 1991
Recent advances in carcinoids and gastrointestinal neuroendocrine tumorsR L Basser, M D Green
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Thrombopoietin: an update on therapeutic potentialC R Underhill, R L Basser
Cancer Investigation|August 7, 2001
ThrombopoietinR L Basser, C G Begley
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Stem Cells (Dayton, Ohio)|September 30, 2000
Early Australian clinical studies with pegylated recombinant human megakaryocyte growth and development factorR L Basser
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
Dose-intensive chemotherapy in breast cancer--the need for appropriate measures of outcomeR L Basser
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
New developments in high-dose chemotherapy for breast cancerR L Basser
Stem Cells (Dayton, Ohio)|January 1, 1996
The role of platelet growth factors in cancer therapyK Clarke, R L Basser
International Journal of Hematology|January 17, 2002
Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agentsR L Basser, C G Begley
Seminars in Hematology|June 1, 2000
Biologic and structural differences of thrombopoietic growth factorsC G Begley, R L Basser
Cancer Treatment Reviews|January 1, 1993
Strategies for prevention of anthracycline cardiotoxicityR L Basser, M D Green
Current Opinion in Oncology|February 1, 1991
Recent advances in carcinoids and gastrointestinal neuroendocrine tumorsR L Basser, M D Green
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Thrombopoietin: an update on therapeutic potentialC R Underhill, R L Basser
Cancer Investigation|August 7, 2001
ThrombopoietinR L Basser, C G Begley
Pageof 4